145 related articles for article (PubMed ID: 34818983)
1. Demographic and Clinical Correlates of Treatment Completion among Older Adults with Heroin and Prescription Opioid Use Disorders.
Choi NG; DiNitto DM; Marti CN; Choi BY
J Psychoactive Drugs; 2022; 54(5):440-451. PubMed ID: 34818983
[TBL] [Abstract][Full Text] [Related]
2. Older-Adult Marijuana Users in Substance Use Treatment: Characteristics Associated with Treatment Completion.
Choi NG; DiNitto DM
J Psychoactive Drugs; 2020; 52(3):218-227. PubMed ID: 32252613
[TBL] [Abstract][Full Text] [Related]
3. Residential and outpatient treatment completion for substance use disorders in the U.S.: Moderation analysis by demographics and drug of choice.
Stahler GJ; Mennis J; DuCette JP
Addict Behav; 2016 Jul; 58():129-35. PubMed ID: 26925821
[TBL] [Abstract][Full Text] [Related]
4. Racial/Ethnic Differences in Prevalence Trends for Heroin use and Non-Medical use of Prescription Opioids Among Entrants to Opioid Treatment Programs, 2005-2016.
Pouget ER; Fong C; Rosenblum A
Subst Use Misuse; 2018 Jan; 53(2):290-300. PubMed ID: 28854060
[TBL] [Abstract][Full Text] [Related]
5. Increasing trend in accidental pharmaceutical opioid overdose deaths and diverging overdose death correlates following the opioid prescription policy liberalization in Norway 2010-2018.
Gjersing L; Amundsen E
Int J Drug Policy; 2022 Oct; 108():103785. PubMed ID: 35907371
[TBL] [Abstract][Full Text] [Related]
6. Overdose deaths from nonprescribed prescription opioids, heroin, and other synthetic opioids in Medicare beneficiaries.
Kuo YF; Baillargeon J; Raji MA
J Subst Abuse Treat; 2021 May; 124():108282. PubMed ID: 33771281
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcome disparities for opioid users: Are there racial and ethnic differences in treatment completion across large US metropolitan areas?
Stahler GJ; Mennis J
Drug Alcohol Depend; 2018 Sep; 190():170-178. PubMed ID: 30041092
[TBL] [Abstract][Full Text] [Related]
8. Late- and Typical-Onset Heroin Use Among Older Adults Seeking Treatment for Opioid Use Disorder.
Lynch A; Arndt S; Acion L
Am J Geriatr Psychiatry; 2021 May; 29(5):417-425. PubMed ID: 33353852
[TBL] [Abstract][Full Text] [Related]
9. Association of Medication-Assisted Treatment and Age With Treatment Completion Among Veterans Seeking Non-VA Treatment for Opioid use Disorder at Non-Veterans Health Administration Facilities.
Pickard JG; van den Berk-Clark C; Matthieu MM
Mil Med; 2022 Mar; 187(3-4):504-512. PubMed ID: 34173832
[TBL] [Abstract][Full Text] [Related]
10. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Collins ED; Kleber HD; Whittington RA; Heitler NE
JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
[TBL] [Abstract][Full Text] [Related]
11. Correlates of specialty substance use treatment among adults with opioid use disorders.
Romo E; Ulbricht CM; Clark RE; Lapane KL
Addict Behav; 2018 Nov; 86():96-103. PubMed ID: 29551551
[TBL] [Abstract][Full Text] [Related]
12. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
Day E; Strang J
J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
[TBL] [Abstract][Full Text] [Related]
13. A nonopioid procedure for outpatient opioid detoxification.
Ockert DM; Volpicelli JR; Baier AR; Coons EE; Fingesten A
J Addict Med; 2011 Jun; 5(2):110-4. PubMed ID: 21769056
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users.
Nielsen S; Hillhouse M; Mooney L; Ang A; Ling W
J Subst Abuse Treat; 2015 Jan; 48(1):70-6. PubMed ID: 25065489
[TBL] [Abstract][Full Text] [Related]
15. A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder.
Huhn AS; Strain EC; Tompkins DA; Dunn KE
Drug Alcohol Depend; 2018 Dec; 193():142-147. PubMed ID: 30384321
[TBL] [Abstract][Full Text] [Related]
16. Estimating State Transitions for Opioid Use Disorders.
Krebs E; Min JE; Evans E; Li L; Liu L; Huang D; Urada D; Kerr T; Hser YI; Nosyk B
Med Decis Making; 2017 Jul; 37(5):483-497. PubMed ID: 28027027
[TBL] [Abstract][Full Text] [Related]
17. Trends in opioid initiation among people who use opioids in three US cities.
Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
Drug Alcohol Rev; 2020 May; 39(4):375-383. PubMed ID: 32249463
[TBL] [Abstract][Full Text] [Related]
18. Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults.
Jarvis BP; Holtyn AF; Berry MS; Subramaniam S; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
J Subst Abuse Treat; 2018 Feb; 85():38-44. PubMed ID: 28449955
[TBL] [Abstract][Full Text] [Related]
19. Young adults' opioid use trajectories: From nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose.
Guarino H; Mateu-Gelabert P; Teubl J; Goodbody E
Addict Behav; 2018 Nov; 86():118-123. PubMed ID: 29747875
[TBL] [Abstract][Full Text] [Related]
20. Treatment utilization among persons with opioid use disorder in the United States.
Wu LT; Zhu H; Swartz MS
Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
